|
|
|
|
|
|
|
|
New Cancer Journal Is Sign of the Times
"Clinicians and researchers interested in the burgeoning field of cancer immunology have a new source of information.
The peer-reviewed Cancer Immunology Research will publish original research on advances in the field, according to its sponsor, the American Association for Cancer Research (AACR).
"Recent clinical successes have validated the longstanding idea that therapeutic manipulation of the immune system may achieve meaningful antitumor effects," said Glenn Dranoff, MD, the founding editor-in-chief, in a press statement. He is professor of medicine at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.